An Open -Label Study to Evaluate the Effect of Combination Therapy With Epothilone D and Herceptin on Tumor Response in Patients With HER-2 Overexpressing Locally Advanced or Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2012
At a glance
- Drugs Epothilone D; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Roche
- 17 Jul 2007 Status changed from in progress to completed.
- 15 Nov 2006 Status change
- 21 Oct 2006 New trial record.